A Microfluidic Blood Brain Barrier Model to Study the Influence of Glioblastoma Tumor Cells on BBB Function
Small · 2025-05 · 21 (19)
DOI: 10.1002/smll.202411361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 04.04.2025. Verfasst von Thomas DePalma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Glioblastoma, Microfluidics, Brain Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Pelotonia, Medical Technology Enterprise Consortium.
Abstract (Originalsprache)
The blood brain barrier (BBB) plays an essential role in regulating brain function by controlling the transport of nutrients and preventing toxins from moving from the rest of the body's circulation into the brain. Because it is more selective than most other endothelial barriers, many therapeutic candidates fail to cross the BBB, making it difficult to design novel drugs to treat many pathologies in the brain. In addition, BBB dysfunction is observed in many brain diseases including glioblastoma (GB), an aggressive, universally fatal primary brain tumor. Here, a novel 3D microfluidic model of the BBB is designed using human cells and a brain‐mimetic hydrogel. The in vitro BBB model replicates several key functions of the human BBB. This system has low permeability to small molecules and responds to inflammatory cues. The addition of GB cells to the model reveals that BBB function changes in a tumor‐cell‐population‐dependent manner. Some GB cell populations lead to increased diffusive permeability while others induce increased immune cell binding. Together, these results indicate that this model can be used to investigate disease progression and drug delivery in GB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA.
- Department of Radiation Oncology, Ohio State University, Columbus, OH, 43210, USA.
- The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.
ORCID-Profile: Aleksander Skardal
Förderung
- NCI NIH HHS
- Pelotonia
- Medical Technology Enterprise Consortium
- National Cancer Institute
Zitieren
APA
DePalma, T., Rodriguez, M., Kollin, L., Hughes, K., Jones, K., Stagner, E., Venere, M., & Skardal, A. (2025). A Microfluidic Blood Brain Barrier Model to Study the Influence of Glioblastoma Tumor Cells on BBB Function. Small, 21(19). https://doi.org/10.1002/smll.202411361
Vancouver
DePalma T, Rodriguez M, Kollin L, Hughes K, Jones K, Stagner E, et al. A Microfluidic Blood Brain Barrier Model to Study the Influence of Glioblastoma Tumor Cells on BBB Function. Small. 2025;21(19). doi:10.1002/smll.202411361
BibTeX
@article{DePalma2025,
author = {DePalma, Thomas and Rodriguez, Marco and Kollin, Luke and Hughes, Kennedy and Jones, Katie and Stagner, Emerie and Venere, Monica and Skardal, Aleksander},
title = {A Microfluidic Blood Brain Barrier Model to Study the Influence of Glioblastoma Tumor Cells on BBB Function},
journal = {Small},
year = {2025},
volume = {21},
number = {19},
doi = {10.1002/smll.202411361}
}
EUVIMED